VOCLENNA

Serial Number 99153642
688

Registration Progress

Application Filed
Apr 24, 2025
Under Examination
Oct 28, 2025
Approved for Publication
Sep 2, 2025
Published for Opposition
Sep 2, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 28, 2026 130 days

Trademark Image

VOCLENNA

Basic Information

Serial Number
99153642
Filing Date
April 24, 2025
Published for Opposition
September 2, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Oct 28, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Janina Gorbach

USPTO Deadlines

Next Deadline
130 days remaining
NOA E-Mailed - SOU Required
Due Date
April 28, 2026
Extension Available
Until October 28, 2026

Application History

9 events
Date Code Type Description Documents
Oct 28, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 2, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 2, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 27, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 1, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 24, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2025 NWAP I NEW APPLICATION ENTERED Loading...
Apr 24, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of vaso-occlusive crisis; Pharmaceutical preparations for the treatment of sickle cell disease

Classification

International Classes
005